Ophthalmology Doctors in Nampa, ID Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Dr. Leo S Harf, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4400 Flamingo Ave E., Suite 300, Nampa, ID 83687 Phone: 208-466-2222    Fax: 208-465-3441

Johanna M Jensen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1615 12th Ave Rd, Ste A, Nampa, ID 83686 Phone: 208-467-4406    Fax: 208-467-4450

Mr. Ryan S. Mckinnon, MD-OPTHALMOLOGY Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-455-2355    Fax: 208-465-4825

Jorge A Martinez, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1615 12th Ave Rd, Ste B, Nampa, ID 83686 Phone: 208-498-1700    Fax: 208-498-1745

Dr. Caroline W Vargason, MD, Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 1603 12th Ave Rd Ste E, Nampa, ID 83686 Phone: 208-466-0255    Fax: 208-807-2331

News Archive

Protein target for Parkinson's disease

Researchers at Johns Hopkins' Institute for Cell Engineering (ICE) have discovered a protein that could be the best new target in the fight against Parkinson's disease since the brain-damaging condition was first tied to loss of the brain chemical dopamine.

Painless tDCS technique could improve life for people with major depression

Small amounts of electricity similar to the output of a common 9-volt battery could improve life for people living with major depression, the most common mood disorder.

Omeros identifies orphan GPCR compound that potentiates tumor-killing activity of doxorubicin

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that a compound identified by the Company as an antagonist of GPR87, an orphan GPCR recently unlocked for drug development by Omeros and linked to squamous cell carcinoma, potentiates the tumor-killing activity of doxorubicin (Adriamycin), a widely used chemotherapeutic agent.

Delirium in ICU associated with lengthier hospital stays and greater risk of death

About one-third of patients admitted to an intensive care unit (ICU) will develop delirium, a condition that lengthens hospital stays and substantially increases one's risk of dying in the hospital, according to a new study led by Johns Hopkins Medicine researchers appearing in the British Medical Journal.

Opioid use during pregnancy can cause long-lasting impairment in the infant's brain

As the number of pregnant women using opioid drugs continues to rise, questions have been raised about the long-term health effects on children exposed to these drugs in the womb.

Read more Medical News

› Verified 2 days ago